This grant is concerned with the ontogenesis of B cells and mutations that affect it. The experiments are designed to test a new hypothesis, based on several novel experiments which explain the origin and phenotype of CD5+ B cells on the one hand and memory B cells on the other. The proposal is that CD5 is induced by slg cross-linking (thymus independent type 2 [TI-2]) antigens, but not thymus dependent (TD), antigens. In contrast, cognate T helper-B cell interactions in response to T dependent antigens induce the generation of memory B cells which remain CD5 and decrease surface j11d. This model will be extensively tested during this grant period. This is important to do because validation of the hypothesis promises to give insight into several outstanding immunological problems, such as the origins of the CD5+ cells which are responsible for the production of a prominent form of autoantibody (so-called """"""""natural"""""""" or low-affinity antibody), and the pathogenesis of chronic lymphatic leukemia which is characterized by an expansion of CD5+ cells. Further, the definition of the conditions for the induction of memory B cells would provide a system for studying the regulation of the mutation process. The proposed experiments are designed to test the basic features of the model. In addition, the basis for the regulated expression of CD5 will be determined. A direct test of a system for inducing somatic mutation in immunoglobulin in vitro is proposed. Finally, the basis for a heightened sensitivity of CD5 cells to deletion by programmed cell death will be examined.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI015803-16
Application #
2060295
Study Section
Immunological Sciences Study Section (IMS)
Project Start
1979-05-01
Project End
1997-04-30
Budget Start
1994-05-01
Budget End
1995-04-30
Support Year
16
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Tufts University
Department
Pathology
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02111
Berland, Robert; Wortis, Henry H (2003) Normal B-1a cell development requires B cell-intrinsic NFATc1 activity. Proc Natl Acad Sci U S A 100:13459-64
Berland, Robert; Wortis, Henry H (2002) Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 20:253-300
Jin, Lei; McLean, Paul A; Neel, Benjamin G et al. (2002) Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling. J Exp Med 195:1199-205
Ma, Limei; Wortis, Henry H; Kenter, Amy L (2002) Two new isotype-specific switching activities detected for Ig class switching. J Immunol 168:2835-46
Wortis, H H; Berland, R (2001) Cutting edge commentary: origins of B-1 cells. J Immunol 166:2163-6
Berland, R; Wortis, H H (2000) Role of NFAT in the regulation of B-1 cells. Curr Top Microbiol Immunol 252:131-40
Bajpai, U D; Zhang, K; Teutsch, M et al. (2000) Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation. J Exp Med 191:1735-44
Doody, G M; Billadeau, D D; Clayton, E et al. (2000) Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes. EMBO J 19:6173-84
Novina, C D; Kumar, S; Bajpai, U et al. (1999) Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase. Mol Cell Biol 19:5014-24
Berland, R; Wortis, H H (1998) An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells. J Immunol 161:277-85

Showing the most recent 10 out of 23 publications